Expert Interview
Examining the topline results from the Phase 2b FRONTIER 1 clinical trial of Johnson & Johnson's JNJ-2113 in patients with Plaque Psoriasis.
Ticker(s): JNJ, ABBVInstitution: Boston University School of Medicine and Boston Medical Center
- Associate Professor of Dermatology; Director of the Boston University Center for Ethnic Skin and Founder of the Cosmetic and Laser Center at Boston Medical Center
- Treats 50 patients with hidradenitis suppurativa
- Specializes in research for skin of color dermatology and pigmentary disorders, with expertise in conditions such as melasma, vitiligo, and post-inflammatory hyperpigmentation. Leads clinical research and trials focused on novel therapies and laser technologies
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
